19/02/2026
Another Academic Event with Health Care professionals of multispeciality emphasising health benefits of weight reduction,obesity related metabolic complications guidelines focusing obesity management and the role of the twin incretin tirzepatide in obesity and obesity-related metabolic and mechanical complications, including diabetes, cardiovascular disease (CVD), metabolic dysfunction–associated fatty liver disease (MAFLD), and obstructive sleep apnea.
Session was well moderated by Dr Mohsin Amin Rajput.
Session was Enlightened and Enriched by Discussion of panelists Dr Pooran Kumar,Prof Raheel Sikander,Dr Abrar.
This session was attended by a large and diverse audience, including physicians, endocrinologists, gynecologists, dermatologists, and family physicians. It concluded with an engaging and interactive discussion, followed by a comprehensive question-and-answer session with participants from various specialties.
My sincere thanks to Getz Pharma for organizing such a wonderful and well-coordinated session.
